Qube Research & Technologies LTD Ani Pharmaceuticals Inc Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 76,185 shares of ANIP stock, worth $7.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,185
Previous 35,704
113.38%
Holding current value
$7.05 Million
Previous $2.39 Million
107.99%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ANIP
# of Institutions
251Shares Held
20MCall Options Held
19.9KPut Options Held
12.8K-
Black Rock Inc. New York, NY2.66MShares$246 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$118 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$92.9 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$79.8 Million3.45% of portfolio
-
State Street Corp Boston, MA716KShares$66.3 Million0.0% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.61B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...